A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals.
Joris DeelenJohannes KettunenKrista FischerAshley van der SpekStella TrompetGabi KastenmüllerAndrew BoydJonas ZiererErik Ben van den AkkerMika Ala-KorpelaNajaf AminAyse DemirkanMohsen GhanbariDiana van HeemstMohammad Arfan IkramJan Bert van KlinkenSimon P MooijaartAnnette PetersVeikko V SalomaaNaveed SattarTim D SpectorHenning TiemeierAswin VerhoevenMelanie WaldenbergerPeter WürtzGeorge Davey SmithAndres MetspaluMarkus PerolaCristina MenniJohanna Marianna GeleijnseFotios DrenosMarian BeekmanJohan Wouter JukemaCornelia M van DuijnP Eline SlagboomPublished in: Nature communications (2019)
Predicting longer-term mortality risk requires collection of clinical data, which is often cumbersome. Therefore, we use a well-standardized metabolomics platform to identify metabolic predictors of long-term mortality in the circulation of 44,168 individuals (age at baseline 18-109), of whom 5512 died during follow-up. We apply a stepwise (forward-backward) procedure based on meta-analysis results and identify 14 circulating biomarkers independently associating with all-cause mortality. Overall, these associations are similar in men and women and across different age strata. We subsequently show that the prediction accuracy of 5- and 10-year mortality based on a model containing the identified biomarkers and sex (C-statistic = 0.837 and 0.830, respectively) is better than that of a model containing conventional risk factors for mortality (C-statistic = 0.772 and 0.790, respectively). The use of the identified metabolic profile as a predictor of mortality or surrogate endpoint in clinical studies needs further investigation.